- Home
- SPRY vs BALY Comparison
SPRY vs BALY Comparison
Compare SPRY & BALY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SPRY | BALY |
|---|---|---|
| Founded | 2015 | 2004 |
| Country | United States | United States |
| Employees | N/A | 11700 |
| Industry | Biotechnology: Pharmaceutical Preparations | Hotels/Resorts |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 788.5M | 731.8M |
| IPO Year | 2020 | 2019 |
Fundamental Metrics
Financial Performance| Metric | SPRY | BALY |
|---|---|---|
| Price | $6.02 | $13.71 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 5 |
| Target Price | ★ $40.00 | $12.40 |
| AVG Volume (30 Days) | ★ 2.3M | 62.1K |
| Earning Date | 05-11-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 8.37 |
| EPS | ★ N/A | N/A |
| Revenue | $84,278,000.00 | ★ $2,436,189,000.00 |
| Revenue This Year | $87.40 | $21.50 |
| Revenue Next Year | $81.64 | $5.45 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.77 | $8.79 |
| 52 Week High | $18.63 | $20.74 |
Technical Indicators
Market Signals| Indicator | SPRY | BALY |
|---|---|---|
| Relative Strength Index (RSI) | 28.16 | 49.16 |
| Support Level | N/A | $12.43 |
| Resistance Level | $8.61 | $14.45 |
| Average True Range (ATR) | 0.44 | 0.81 |
| MACD | -0.18 | 0.05 |
| Stochastic Oscillator | 13.90 | 57.75 |
Price Performance
Historical ComparisonAbout SPRY ARS Pharmaceuticals Inc.
ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the commercialization and development of neffy (currently identified in the European Union (EU) and United Kingdom (U.K.) by the trade name EURneffy and in China) for needle-free intranasal delivery of epinephrine for emergency treatment of Type I allergic reactions, including anaphylaxis. Neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows Neffy to safely provide intranasal delivery of epinephrine at a low dose within the exposures of approved injectable products across a range of dosing conditions.
About BALY Bally's Corporation
Ballys Corp is a gaming, hospitality, entertainment, and technology company operating across casino, interactive, and lottery markets. It provides physical and interactive gaming experiences, including casino gaming, iGaming, sportsbook, online bingo, free-to-play games, and technology-driven lottery solutions. The company's segments include Casinos & Resorts, which generates maximum revenue and operates casino and resort properties, a horse racetrack, and a golf course; Bally's Intralot B2B, which provides lottery and technology services; Bally's Intralot B2C, which includes interactive gaming and lottery operations, including a UK casino; and North America Interactive, which includes sports betting and iGaming operations in the United States and Canada.